Posted inNews
FICAN (Comprehensive Cancer Center Finland) Director position open
FICAN (Comprehensive Cancer Center Finland) and its coordinating unit, is seeking a Director of the Finnish Read More »
Breakthrough research for improved cancer diagnostics and treatments
iCAN aims to improve outcomes and quality of life of cancer patients.
We do this through cutting-edge research focused on improving understanding in immuno-oncology, tumor microenvironment and development of disease resistance.
Our research projects leverage the iCAN discovery platform to identify new targets and solutions for diagnosing and treating cancer.
Integrating tumor molecular profiling and patients’ health data
The iCAN discovery platform links molecular profiling of tumors with broader health data of cancer patients, acting as a catalyst for breakthrough research and technologies.
The scale of data – 15,000 samples across different cancer types will be profiled by 2026 – enables real impact and broad studies across different cancer types.
The platform will enable an improved understanding of the complex interplay between cancer cells and the host.
Accelerating world-class scientific innovation with the patient in focus
Our approach is to keep the patient in the focus in all activities in developing a research and innovation hub in digital precision cancer medicine.
At the heart of the ecosystem is the iCAN discovery platform leveraged in collaborative partnerships among researchers and the life science industry.
Our latest news
05 Sep, 2021
18 Aug, 2021
Posted inNews
Kiinnostaako iCAN-tutkimushanke? Tervetuloa Suomen Syöpäpotilaat ry:n webinaariin
Suomen Syöpäpotilaat ry:n 50-vuotisjuhlavuoden kunniaksi järjestettävä webinaarisarja meneillään olevista syöpätutkimushankkeista alkaa elokuun lopussa. Ensimmäisenä aiheena torstaina 26.8. Read More »
10 Aug, 2021
Posted inNews
Syöpä koskettaa jokaista – Geenitiedolla kohti yksilöllisempää hoitoa -keskustelutilaisuus 8.9.2021
Syöpä koskettaa tavalla tai toisella meistä ihan jokaista. Meihin kaikkiin siis vaikuttaa, miten syöpää hoidetaan ja Read More »
29 Jun, 2021
Posted inNews
iCAN käynnistää syöpänäytteiden molekyyliprofiloinnin tulevana syksynä
Laajassa, eri syöpätyyppejä tarkastelevassa tutkimuksessa tarkkaa tietoa syöpäkasvaimesta yhdistetään potilaan muihin terveystietoihin uudenlaisella tavalla. Tutkittavat näytteet kerätään Read More »
Strong recommendations how to increase clinical trials for cancer patients in Finland from the @Cancer_IO_ consortium. Chipping in by providing a molecular profiling & IO platform - hopefully to go national soon! @FICAN_Finland @FicanSouth @ficaneast @CancerInstFIN
Strong editorial from @hsfi - does not make any sense to (further) cut funding of the internationally competitive and attractive (including cancer research!) @helsinkiuni when Finland desperately needs to recruit a lot of talent https://www.hs.fi/paakirjoitukset/art-2000008269938.html?share=df09c2a1b9fe2c935189333de14f171c
First #preprint out from @SystemTumor on @researchsquare: Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer https://www.researchsquare.com/article/rs-257705/latest @HelsinkiUniMed @iCAN_Finland
iCAN is part of the Academy of Finland Flagship Programme and hosted by the University of Helsinki
and HUS Helsinki University Hospital
